|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61K 38/26 | (2013.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61P 9/12 | (2006.01) |
| (11) | Patento numeris | 3426284 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17710231.6 |
| Europos patento paraiškos padavimo data | 2017-03-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/055679 |
| Data | 2017-03-10 |
| (87) | Numeris | WO 2017/153575 |
| Data | 2017-09-14 |
| (30) | Numeris | Data | Šalis |
| 201662306121 P | 2016-03-10 | US |
| (72) |
BEDNAREK, Maria, Aleksandra , GB
JERMUTUS, Lutz, Ulrich , GB
AMBERY, Philip , GB
PETRONE, Marcella , GB
|
| (73) |
MedImmune Limited ,
1 Francis Crick Avenue
Cambridge Biomedical Campus, Cambridge CB2 0AA,
GB
|
| (54) | GLP-1/GLUCAGON AGONIST FOR USE IN THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS |
| GLP-1/GLUCAGON AGONIST FOR USE IN THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS |